20n Bio is a VC-backed start-up dedicated to designing and screening cyclic peptides for therapeutics.
20n Bio has raised $7.5M in total funding. The most recent round was Seed. The last funding was announced in May 2026.
20n Bio is headquartered in Malvern, United States.
20n Bio is a VC-backed start-up dedicated to designing and screening cyclic peptides for therapeutics.
20n Bio is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"20n Bio — Funding & Investors." VCBacked, May 20, 2026, https://www.vcbacked.co/company/20n-bio. Accessed August 14, 2026.
VCBacked. (2026). 20n Bio — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/20n-bio
{{cite web |title=20n Bio — Funding & Investors |url=https://www.vcbacked.co/company/20n-bio |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated